Rosetta Genomics announced that it has named Robert Wassman as its new chief medical officer and Dganit Bar as its new chief scientific officer.
Wassman is a medical geneticist and has held various executive positions at companies including Genzyme Genetics. He most recently served as CMO at Generation Health.
Bar joins Rosetta from BioLineRx, where she served as executive director of science and technology. She also worked at QBI Enterprises, a subsidiary of Quark Pharmaceuticals.
Benitec Biopharma announced that Tacere Therapeutics' director of research and development, David Suhy, has been named its new senior vice president of research and development.
Suhy's appointment comes with Benitec's acquisition of Tacere.